TACRINE HYDROCHLORIDE
Tacrine hydrochloride is an acetylcholinesterase inhibitor that was one of the first medications approved for the treatment of Alzheimer's disease. By increasing levels of acetylcholine in the brain, tacrine aims to enhance cognitive function and slow the progression of symptoms associated with dementia. Although it can improve cognitive abilities in some patients, its use has diminished due to side effects, such as gastrointestinal issues and hepatotoxicity, as well as the availability of newer, more effective treatments.